Literature DB >> 24297901

Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA.

Le Xuan Truong Nguyen1, Beverly S Mitchell.   

Abstract

Transcription initiation factor I (TIF-IA) plays an essential role in regulating ribosomal RNA (rRNA) synthesis by tethering RNA polymerase I (Pol I) to the rDNA promoter. We have found that activated Akt enhances rRNA synthesis through the phosphorylation of casein kinase IIα (CK2α) on a threonine residue near its N terminus. CK2 in turn phosphorylates TIF-IA, thereby increasing rDNA transcription. Activated Akt also stabilizes TIF-IA, induces its translocation to the nucleolus, and enhances its interaction with Pol I. Treatment with AZD8055, an inhibitor of both Akt and mammalian target of rapamycin phosphorylation, but not with rapamycin, disrupts Akt-mediated TIF-IA stability, translocation, and activity. These data support a model in which activated Akt enhances rRNA synthesis both by preventing TIF-IA degradation and phosphorylating CK2α, which in turn phosphorylates TIF-IA. This model provides an explanation for the ability of activated Akt to promote cell proliferation and, potentially, transformation.

Entities:  

Keywords:  PKB/Akt; acute myelogenous leukemia

Mesh:

Substances:

Year:  2013        PMID: 24297901      PMCID: PMC3870716          DOI: 10.1073/pnas.1313097110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia.

Authors:  Roel Polak; Miranda Buitenhuis
Journal:  Blood       Date:  2011-11-07       Impact factor: 22.113

2.  Proteasomal ATPases are associated with rDNA: the ubiquitin proteasome system plays a direct role in RNA polymerase I transcription.

Authors:  Károly Fátyol; Ingrid Grummt
Journal:  Biochim Biophys Acta       Date:  2008-09-06

3.  AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.

Authors:  Joanna C Chan; Katherine M Hannan; Kim Riddell; Pui Yee Ng; Abigail Peck; Rachel S Lee; Sandy Hung; Megan V Astle; Megan Bywater; Meaghan Wall; Gretchen Poortinga; Katarzyna Jastrzebski; Karen E Sheppard; Brian A Hemmings; Michael N Hall; Ricky W Johnstone; Grant A McArthur; Ross D Hannan; Richard B Pearson
Journal:  Sci Signal       Date:  2011-08-30       Impact factor: 8.192

4.  CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival.

Authors:  Daniela P Ponce; Roger Yefi; Pablo Cabello; Jose L Maturana; Ignacio Niechi; Eduardo Silva; Mario Galindo; Marcelo Antonelli; Katherine Marcelain; Ricardo Armisen; Julio C Tapia
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

5.  Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells.

Authors:  Patrizia Sini; Dominic James; Christine Chresta; Sylvie Guichard
Journal:  Autophagy       Date:  2010-05-16       Impact factor: 16.016

6.  AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.

Authors:  Christine M Chresta; Barry R Davies; Ian Hickson; Tom Harding; Sabina Cosulich; Susan E Critchlow; John P Vincent; Rebecca Ellston; Darren Jones; Patrizia Sini; Dominic James; Zoe Howard; Phillippa Dudley; Gareth Hughes; Lisa Smith; Sharon Maguire; Marc Hummersone; Karine Malagu; Keith Menear; Richard Jenkins; Matt Jacobsen; Graeme C M Smith; Sylvie Guichard; Martin Pass
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

7.  Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells.

Authors:  Giovanni Di Maira; Francesca Brustolon; Lorenzo A Pinna; Maria Ruzzene
Journal:  Cell Mol Life Sci       Date:  2009-08-08       Impact factor: 9.261

Review 8.  The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer.

Authors:  Denis Drygin; William G Rice; Ingrid Grummt
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

Review 9.  RNA polymerases I and III, non-coding RNAs and cancer.

Authors:  Robert J White
Journal:  Trends Genet       Date:  2008-11-06       Impact factor: 11.639

10.  AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply.

Authors:  Sven Hoppe; Holger Bierhoff; Ivana Cado; Andrea Weber; Marcel Tiebe; Ingrid Grummt; Renate Voit
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-06       Impact factor: 11.205

View more
  30 in total

1.  TIF-90 tips the balance in rRNA synthesis.

Authors:  Katherine L B Borden
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

2.  Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.

Authors:  Stefano Rossetti; Andrzej J Wierzbicki; Nicoletta Sacchi
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

3.  Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.

Authors:  Alice Melão; Maureen Spit; Bruno A Cardoso; João T Barata
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

4.  Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.

Authors:  Janeen H Trembley; Gretchen M Unger; Omar Cespedes Gomez; J Abedin; Vicci L Korman; Rachel I Vogel; Gloria Niehans; Betsy T Kren; Khalil Ahmed
Journal:  Mol Cell Pharmacol       Date:  2014

5.  Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6.

Authors:  Ana Paula Zen Petisco Fiore; Virginia A Spencer; Hidetoshi Mori; Hernandes F Carvalho; Mina J Bissell; Alexandre Bruni-Cardoso
Journal:  Cell Rep       Date:  2017-06-06       Impact factor: 9.423

Review 6.  TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis.

Authors:  Rui Jin; Wei Zhou
Journal:  Biochim Biophys Acta       Date:  2016-09-15

7.  A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction.

Authors:  Marianeve Carotenuto; Pasqualino de Antonellis; Cristina Maria Chiarolla; Carmela Attanasio; Valentina Damiani; Iolanda Boffa; Nadia Aiese; Emilia Pedone; Benedetta Accordi; Giuseppe Basso; Luigi Navas; Ciro Imbimbo; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-20       Impact factor: 3.000

8.  High CO2 Downregulates Skeletal Muscle Protein Anabolism via AMP-activated Protein Kinase α2-mediated Depressed Ribosomal Biogenesis.

Authors:  Tanner C Korponay; Joseph Balnis; Catherine E Vincent; Diane V Singer; Amit Chopra; Alejandro P Adam; Roman Ginnan; Harold A Singer; Ariel Jaitovich
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

9.  SI-MOIRAI: a new method to identify and quantify the metabolic fate of nucleotides.

Authors:  Yoshiki Ikeda; Akiyoshi Hirayama; Satoshi Kofuji; Yoshihisa Hirota; Ryo Kamata; Natsuki Osaka; Yuki Fujii; Mika Sasaki; Satsuki Ikeda; Eric P Smith; Robert Bachoo; Tomoyoshi Soga; Atsuo T Sasaki
Journal:  J Biochem       Date:  2022-01-07       Impact factor: 3.241

10.  MicroRNA networks in FLT3-ITD acute myeloid leukemia.

Authors:  Dinh Hoa Hoang; Dandan Zhao; Sergio Branciamore; Davide Maestrini; Ivan R Rodriguez; Ya-Huei Kuo; Russell Rockne; Samer K Khaled; Bin Zhang; Le Xuan Truong Nguyen; Guido Marcucci
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-11       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.